MUMBAI, 24 September 2026 — Adroit Industries (India) Limited’s IPO recorded 40,767,969 bid shares for 7,872,900 shares in the issuer-detail demand allocation at 5 p.m. IST on September 23. The resulting subscription multiple is 5.18 times.

Verified details

Company Adroit Industries (India) Limited
Application window 23-Sep-2026 to 25-Sep-2026
Price band Rs. 126 to Rs. 134 per Equity Share
Quoted lot unit 111 Equity Shares and in multiples thereof
Registrar Bigshare Services Private Limited
Demand data timestamp 23-Sep-2026 17:00:00 IST

The headline masks a large category gap

Retail demand was approximately 7.24 times and non-institutional coverage 7.20 times, while qualified institutional coverage stood near 0.05 times. The high overall reading therefore does not mean institutional demand was equally strong. Nor does it promise a seven-to-one allotment calculation for an individual applicant: allocation rules and validated final bids still apply.

Shares issued versus shares sold

The exchange terms identify up to 9,897,000 fresh shares and 1,350,000 OFS shares. At ₹134, multiplying those quantities gives ₹132.6198 crore and ₹18.09 crore respectively, or ₹150.7098 crore combined before offer expenses. This calculation uses the upper endpoint, not an announced final issue price. The 3,374,100-share anchor portion is included and should not be counted twice.

Timetable and source choice

Bidding runs September 23–25 at ₹126–₹134 with a 111-share lot; one lot at the top of the band is ₹14,874. Bigshare Services is registrar. The general current-issue feed retained an older 3.06-times number at capture, so this article explicitly uses the dated issuer-detail record. It is a first-day closing snapshot, not live demand for the new session.

Source check: CapKet retrieved the linked exchange records at approximately 00:57 IST on 24 September 2026. Event dates and source update times are distinguished from this publication date. Later corrections may change the official record.

Disclosure: AI-assisted, independently written reporting from attributed public records; no independent human review is claimed. This is general information, not an investment recommendation. No listing return, dividend receipt or buyback acceptance is guaranteed.